Notch Signaling Induces SKP2 Expression and Promotes Reduction of P27Kip1 in T-cell Acute Lymphoblastic Leukemia Cell Lines
Overview
Authors
Affiliations
In T-cell acute lymphoblastic leukemia (T-ALL) NOTCH 1 receptors are frequently mutated. This leads to aberrantly high Notch signaling, but how this translates into deregulated cell cycle control and the transformed cell type is poorly understood. In this report, we analyze downstream responses resulting from the high level of NOTCH 1 signaling in T-ALL. Notch activity, measured immediately downstream of the NOTCH 1 receptor, is high, but expression of the canonical downstream Notch response genes HES 1 and HEY 2 is low both in primary cells from T-ALL patients and in T-ALL cell lines. This suggests that other immediate Notch downstream genes are activated, and we found that Notch signaling controls the levels of expression of the E3 ubiquitin ligase SKP2 and its target protein p27Kip1. We show that in T-ALL cell lines, recruitment of NOTCH 1 intracellular domain (ICD) to the SKP2 promoter was accompanied by high SKP2 and low p27Kip1 protein levels. In contrast, pharmacologically blocking Notch signaling reversed this situation and led to loss of NOTCH 1 ICD occupancy of the SKP2 promoter, decreased SKP2 and increased p27Kip1 expression. T-ALL cells show a rapid G1-S cell cycle transition, while blocked Notch signaling resulted in G0/G1 cell cycle arrest, also observed by transfection of p27Kip1 or, to a smaller extent, a dominant negative SKP2 allele. Collectively, our data suggest that the aberrantly high Notch signaling in T-ALL maintains SKP2 at a high level and reduces p27Kip1, leading to more rapid cell cycle progression.
SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies.
William J, Dhar R, Gundamaraju R, Sahoo O, Pethusamy K, Raj A Front Oncol. 2024; 14:1288501.
PMID: 38559562 PMC: 10978726. DOI: 10.3389/fonc.2024.1288501.
Identification of a Notch transcriptomic signature for breast cancer.
Braune E, Geist F, Tang X, Kalari K, Boughey J, Wang L Breast Cancer Res. 2024; 26(1):4.
PMID: 38172915 PMC: 10765899. DOI: 10.1186/s13058-023-01757-7.
Jandrey E, Barnabe G, Maldaun M, Asprino P, Dos Santos N, Inoue L Neurooncol Adv. 2023; 5(1):vdad147.
PMID: 38024245 PMC: 10681280. DOI: 10.1093/noajnl/vdad147.
NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.
Deshotels L, Safa F, Saba N Int J Mol Sci. 2023; 24(12).
PMID: 37373427 PMC: 10299455. DOI: 10.3390/ijms241210280.
NetBID2 provides comprehensive hidden driver analysis.
Dong X, Ding L, Thrasher A, Wang X, Liu J, Pan Q Nat Commun. 2023; 14(1):2581.
PMID: 37142594 PMC: 10160099. DOI: 10.1038/s41467-023-38335-6.